Pharmabiz16h
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi
ASPA to host 6th edition of Traceability and Authentication Forum 2025 on March 17 & 18 at New Delhi: Our Bureau, Bengaluru Monday, January 13, 2025, 09:00 Hrs [IST] The Authentic ...
Pharmabiz12h
Harbour BioMed announces license agreement with Windward Bio for HBM9378/SKB378, an anti-TSLP fully human antibody for immunological diseases
Cambridge, Massachusetts Monday, January 13, 2025, 13:30 Hrs [IST] ...
Pharmabiz13h
AIG Group of Hospitals in Hyderabad to invest Rs. 800 crore in Proton Beam Therapy to treat complex cancers
AIG Group of Hospitals in Hyderabad to invest Rs. 800 crore in Proton Beam Therapy to treat complex cancers: Our Bureau, Chennai Monday, January 13, 2025, 12:15 Hrs [IST] The Boar ...
Pharmabiz8h
Qiagen increases QIAcuity Digital PCR High-Order Multiplexing capabilities to gain deeper insights from biological samples
Venlo, Netherlands Monday, January 13, 2025, 17:00 Hrs [IST] ...
Pharmabiz10h
ProMIS Neurosciences begins PRECISE-AD phase 1b trial of lead therapeutic candidate, PMN310 in Alzheimer’s disease
Cambridge, Massachusetts Monday, January 13, 2025, 15:00 Hrs [IST] ...
Pharmabiz12h
GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion
GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion: London, UK Monday, January 13, 2025, 13:35 Hrs [IST] GSK plc and IDRx, Inc. (IDRx) ann ...
Pharmabiz3d
WHO prequalifies SD Biosensor’s STANDARD G6PD System to support safer administration of P. vivax malaria treatments
The World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to ...
Pharmabiz3d
FPME demands policy reforms to address critical issues hampering export ecosystem
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has urged the authorities to address critical issues hampering India's pharmaceutical export ecosystem, highlighting the ...
Pharmabiz3d
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor
Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics for RAS-driven cancers, announced progress across its pipeline ...
Pharmabiz3d
NCH amends BHMS regulations to add goals, restructure curriculum and assessment process
The National Commission for Homoeopathy (NCH), the statutory body under the Ministry of Ayush to regulate the Homoeopathy education in the country, has amended the regulations related to Bachelor of ...
Pharmabiz9h
NIHR-funded research shows AI may help doctors improve the success rates of IVF treatment
NIHR-funded research shows AI may help doctors improve the success rates of IVF treatment: United Kingdom Monday, January 13, 2025, 16:00 Hrs [IST] NIHR-funded research has discov ...
Pharmabiz3d
Lupin’s ivacaftor oral granules receives US FDA tentative approval
Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for ...